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Introduction 
The assembly and the maintenance of the International Space Station is expected to require hundreds 
of extravehicular excursions (EVA's) in the next 10 years. During an EVA, in order to allow movement 
and bending of limbs, spacesuit pressures are reduced to about 4.3 psi. as compared with about 14.7 psi . 
for nonnal atmospheric pressure at sea level. However, the exposure of astronauts to reduced pressures in 
spacesuits, is conducive to fonnation and growth of gas bubbles within venous blood or tissues, which 
could cause decompression illness (DCI), a pathology best known to occur among deep-sea divers when 
they return to the surface. To reduce the risk of DCI, astronauts adjust to the reduced pressure in stages 
for a prolonged time known as a "pre-breathe" period prior to their extravehicular activity. 
Despite the use of pre-breathe protocols, an increased risk of DC I can arise for about 25% of humans 
who have a small hole, known as apatentJoramen ovale (PFO), between two chambers of the heart. The 
atrial septum' s fossa oval is, an embryological remnant of a flap between the septae primum and 
secundum allows fetal right atrial blood to pass into the left atrium, and usually closes after birth (Hagen, 
et al,. 1984) . Iffusion does not occur, a valve-like opening, the foramen ovale persists between the two 
atria. It has been suggested that astronauts with PFO's might be at greater risk of stroke or other serious 
neurological DCI because bubbles from a venous site may traverse a PFO, travel to the aorta and then 
enter the cerebral circulatory system causing a stroke (Figure 1). 
Astronauts are not now screened for PFO's, however consideration is being given to doing so. Here, 
we study three main methods abbreviated here as "ITE", "TCD" and "TEE", for detecting PFO's in 
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living subjects. All involve the introduction of bubbles into a vein, immediately after which a sensory 
probe attempts to detect the bubbles in systemic circulation. Presence of the injected bubbles in the 
systemic circulation is indicative of a PFO. More detailed descriptions are given after the explanation of 
PFO;s under Figure I. Even if a true PFO affects the risk of DCI, there remains a question of how 
effective screening would be if the detection method has errors of omission andlor commission. Of the 
three methods studied here, TEE is the "gold standard", matching autopsy results with near-perfect 
sensitivity and specificity (Schneider, et aI. , (996). However TEE is also the most difficult method to 
implement, requiring an internal esophagal probe, and is therefore not widely used. Currently, the easiest 
to use and most common PFO detection method is TIE, which uses an external chest probe. This method 
has a specificity of near 100%, but suffers from a low sensitivity rate (about 30%). More recently, TCD 
has been developed, which uses ultrasound probes to detect the presence of bubbles in cerebral arteries. 
Studies indicate that TCD is quite effective, having a sensitivity of about 91 % and a specificity of about 
93% (Droste, et aI. , 1999) when applied correctly, however implementation is difficult and requires 
considerable training. 
To date, there has been little published research on the association between real or detected PFO' s 
and risk of cerebral DCI in a reduced-pressure environment (as would be the case with astronauts), 
however there are available studies on PFO-DCI association for divers. Here, we used a form of meta-
analysis of diving studies to estimate the value of screening for PFO's for each ofthe three procedures 
even though each study used only one of the three. A key assumption that would allow us to combine 
the disparate studies was examined. Comparisons of combined results with estimates made separately for 
each technique were also made . 
Statistical Analysis 
Objectives. There were two main objectives of our statistical analysis. The first was to estimate the odds 
ratio for incidence of DCI with respect to whether or not a subject is classified as having a PFO, using a) 
TIE and b) TCD and c) TEE. The second objective was to estimate how much, if any, beneficial effect 
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there would be if potential subjects were screened for PFO using any of the three detection methods. 
Here, we use the convention that a subject is said to "have" a PFO if and only if the latter is detected 
using the "gold-standard" method TEE. To meet both objectives, we used results from five retrospective 
studies of divers who experienced neurological symptoms of DCI. Foramen ovale patency was assessed 
by TTE in two ofthe studies (Moon, et ai., 1989 , Wilmshurst et al., 1989), by TCD in one study [Louge 
and Cantais, 1999], and by TEE in the remaining two studies (Germonpre, et ai. , 1998, Schwerzmann et 
aI. , 200 1). In all five studies, PFO status was also assessed on selected groups of divers who did not 
experience DCI. In addition, we made use of two additional studies (Belkin, et aI., 1994, Droste, et 
aI. , 1999) to obtain estimates of sensitivity and specificity for TTE and TCD respectively. These estimates 
were incorporated in a combined analysis of data from all three detection methods to produce more 
efficient estimates of relevant odds ratios for both analysis objectives. 
Approach. For a subject examined with the k-th detection method, we define X k to be an indicator of 
PFO diagnosis; i. e. let X k = 1 if a PFO is diagnosed; otherwise X k = O. For definiteness, we shall 
henceforth number the methods in this study as follows : k = 1,2,3 denotes TIE, TCD and TEE 
respectively. In a retrospective study involving the k-th method, let Ykj = 1 ifthej-th subject exhibited 
neurological DCI symptoms; otherwiseYkj = O. Also let xkj be the value of Xk for thej-th subject. If there 
is at least one case of DCI and non-DC! in the study, logistic regression can be used to estimate the odds 
ratio 
P(DCl l Xk = J)I P(noDCll Xk = J) 
~ ~ 
P(DCll X k = 0/ P(noDCll X k = 0) 
(1) 
because ·I3Jk = log ORk is the coefficient of Xkj in the model 
(2) 
The coefficient 130k accounts for bias incurred by retrospective inclusion of arbitrary numbers of DCI and 
non-DCI subjects in the study (Collet , 1999, p. 251). In the case of more than one study, data can be 
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combined in one logistic regression model with one common value of [31k, but with study-specific values 
of [30k. Because the risk of neurological DCI is very small, with our without a PFO, ORk is a very good 
approximation to the corresponding risk ratio 
p(De] I X k = 1) 
Pk = p(De] I Xk = 0) . 
In the second objective of this work, we wish to quantify the effectiveness of each detection 
method for screening out subjects potentially susceptible to DCI, based on the presence of a suspected 
(3) 
PFO. For the k-th procedure, subjects passing the screening test all have Xk = 0, hence the risk of DC I for 
such subjects is the denominator of (3). For non-screened subjects, the risk of DCI is simply P(DCI), the 
. . . . . peDe]) 
unconditIOnal probability of DCI. The ratIO Sk = A therefore reflects the efficacy of 
p(De] I X k = 0) 
screening, with larger values corresponding to greater reduction in the risk of DC I. In order to calculate 
estimates of Sk from estimates of Pk, it is necessary to know (or at least have an estimate of) 8k, the 
proportion of subjects expected to be classified as having a PFO using the k-th method . Since by 
definition, 8k = P(Xk = 1), we have P(DCI) = 8kP(DCI I X k = 1) + (1 - 8J P(DCI I X k = 0), hence 
(4) 
In a prospective study of the k-th detection method applied to a random sample of subjects, a 
good estimate of 8k is the proportion of subjects classified as having a PFO. Alternatively, 8k may be 
expressed as 
(5) 
where A. is the incidence of true PFO' s in the general population, Uk = P( X k = 0 I X = I) and f3k = P( Xk = 
I I X = 0). Here, X is an indicator variable which reflects the actual presence of a PFO. (Since TEE is 
assumed to be errorless, X == X J , however for now we remove the "hat" and the subscript "3" to 
emphasize true PFO status.) Because we lacked studies of TIE and TCD applied to randomly selected 
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subjects, we instead used (5) to estimate 81 and 81. Assuming no errors with TEE, we took 83 equal to A. = 
263/975 == 0.27, the widely recognized value obtained by Hagen, et al., 1984. For TIE, we estimated Ul = 
(1- sensitivity), as 0.71 with combined data from the studies of Schwerzmann et al. ,200 1. For this 
detection method, we also assumed the specificity to be unity (Belkin, et al. ,200 1, 1994), hence we took 
131 = (1 - specificity) = O. From a study ofTCD effectiveness (Droste, et al., 1999), we estimated U1 = 0.09 
(sensitivity = 0.91) and 131 = 0.07 (specificity = 0.93). Using (5), we then obtained the estimates 8 I = 
0.078 (TIE) and 82 = 0.297 (TCD). See Table 6 for a summary of these characteristics. 
Combining results. Although results from the study of each detection method can be used independently 
to estimate the DCI risk ratio (3) and the screening benefit ratio (4), it is possible to combine studies of all 
three methods to produce improved estimates of (3) and (4) provided u '" 13k and A. are known and the 
following assumption holds: 
Assumption A: Given that a subject has a true P FO (i. e. detected by TEE) , the risk of DCl during a 
dive is the same whether or not the P FO is also detected by one of the two imperfect methods (ITE 
or TCD). 
Some justification of this assumption is provided by Lynch, et al.(1984) , who demonstrated that the 
amount of saline contrast material across a PFO was not correlated with the magnitude of the right-to-Ieft 
shunting (RLS flow) as detected by TIE. For example, a PFO detected only by TEE and missed by TIE 
or TCD may still allow large amounts of RLS and may therefore lead to paradoxical cerebral 
embolization. Conversely, there are no published conclusive findings that would enable us to conclude 
that a PFO detected by TIE, for example, is somehow more " severe" and is therefore associated with an 
increased risk of paradoxical cerebral embolization . 
With the help of Assumption A, we proceed to express each of the risk ratios Pk in terms pfthe 
risk ratio p for a perfect method. Data from all five studies can then be used in a single analysis to 
estimate each of the Pk. For imperfect detection methods, let P1k = P(DCl l X k = J) and POk = P(DCll 
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X k = 0). Also let the corresponding risks in terms oftrue PFO status be PI = P(DC1 1 X = 1) and Po = 
P(DCI I X = 0) with ratio p = P/Po. By definition, Pik = P(DCl, Xk = 1)/P( Xk = 1) = P(DCl, Xk = 1)/8k 
. The quantity P(DCl, Xk = 1) can be decomposed as follows: 
P(DCL Xk = 1) = P(DC1 1 Xk = 1, X = I)P( Xk = 11 X = I)P(X = 1) 
+ P(DCI I Xk= 1, X= O)P( Xk= 11 X= O)P(X= 0) (6) 
Assumption A is equivalent to the conditional independence of X k from the event of DCI, given that X is 
known; i.e. 
P(DCI I X k ' .4) = P(DCI I.4)· (7) 
Under this assumption, the expression (6) becomes PI (1 - aJJA + Pof3k(I-A) . Thus 
(8) 
where 8k is given by (5). It follows that Plk is a weighted average of PI and Po; i.e. 
(9) 
where Wlk = (1 - aJJN'Bk. Using a similar approach for Po", it can be shown that 
(10) 
.where WOk = (1 - f3JJ(1 - A)/(1 - 8J. Finally, we have 
(11) 
In our case, we had results from five studies, summarized in Tables 1-5. In general, suppose the 
i-th study used Method k, with Yij denoting the DCI indicator variable for the j-th subject. Then the 
logistic model (2) applied to this data is of the form 
logit P(yij = 1) = f30i + f3/ixij (12) 
where xij = Xk for thej-th subject and f31j = log ORk . However, since ORk == Pk. we may express f31i in 
tenns ofp: 
,--
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(13) 
With Uk. 13k and A known, W/k and W Ok also become known. From the logistic model (13), we then 
estimated the parameters p and 130/, .. ,1305 by maximum likelihood using the statistical software Stata 
(references). We then estimated Pk by 
(14) 
where p is the maximum likelihood estimate of p . Confidence limits for p and the p k were obtained from 
the standard error matrix and are shown in Table TBD2. Finally, point estimates and confidence intervals 
for Pk were substituted into (4) to obtain confidence limits for the screening benefit ratio for each 
procedure. 
Results 
Tables 1-5 show raw tabulations of PFO and DCI outcomes obtained from the five retrospective 
studies used in the various analyses. Using only the data pertaining to each procedure, estimates of odds 
ratios and log odds ratios quantifying the effect of PFO status on DCI risk are shown along with 95% 
confidence limits in Table 7. Since the overall risk of neurological DCI is very small, odds ratios are 
considered equivalent to risk ratios. All logs are natural. Note that because of limited amounts of data, the 
confidence intervals are quite wide. Nevertheless, all three lower 95% confidence limits exceeded one, 
indicating a significant role for diagnosed PFO status (by any of the three methods) as a predictor of the 
risk of DCI. Improved estimates obtained from combining the studies under Assumption A are shown in 
the first part of Table 8. Plots of point estimates and corresponding 95% confidence intervals for the log 
risk ratio with both the separate and combined data are shown in Figure 2. Note how the addition of the 
accurate TEE and relatively accurate TCD data dramatically improved the precision of the log risk ratio 
estimate for TIE. On the other hand, including less accurate TIE and TCD data did not substantially 
reduce the width of the confidence interval for the TEE log risk ratio. The width of the corresponding 
/ 
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confidence interval for TCD was somewhat reduced, suggesting that use ofthe TEE data improved 
precision for TCD, but that the TIE data did not substantially help. 
Screening benefit ratios Sk , calculated from (4) are also shown in Table 8. Although the benefit 
of using TTE to screen is statistically significant (lower confidence limit> 1.0), there appears to be little 
practical benefit for screening with TIE. On the other hand, even with the fairly large uncertainty in the 
estimate, we could conclude that screening with TCD or TEE would considerably reduce the risk of DC I. 
Discussion 
A method has been given that allows one to combine the results of studies with disparate 
diagnostic procedures, to obtain more efficient estimates of screening effectiveness for an outcome (in 
this case DCI) whose risk is presumably affected by the condition being diagnosed (in this case PFO) by 
the diagnostic procedures. In order for the method to work, the risk of the outcome must be low enough, 
with or without the condition, so that odds ratios are essentially equivalent to risk ratios. In addition, a key 
assumption (Assumption A) that allows the combination method to work, is that the risk of the outcome is 
unchanged by diagnosis of the condition using an imperfect procedure, given that the condition actually 
does or does not hold. This would not be the case, for example, if TIE misses " small" PFO ' s that do not 
contribute to increased risk of DCI, but finds " large" PFO' s which do increase the risk of DC I. 
How valid is this assumption for TIE? For notational simplicity, let X == X I , a == al and 13 == 131. 
Applying Assumption A to (6) yields 
P( X =1, DCI) = Pd1 - a) )... + Po13 (1-)...) 
where PI = P(DCI I X = 1) and Po = P(DCI I X = 0). Thus 
P( X=1 IDCI) = PI(i-a))... + Po13(i-)...) 
API + (1- )",)Po 
For TIE, 13 = 0, hence (16) becomes 
(15) 
(16) 
(1 7) 
r~-
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Equation (1 7) states that the proportion of DC I subjects diagnosed by TIE as having PFO's cannot 
exceed 0.29, even if every one of these subjects actually had a PFO. In view of (1 7) it is extremely 
unlikely that as many as 11 of 18 DCI subjects in Study 1 could have been diagnosed with PFO' s by TIE 
(P < .005) or that at least 19 of29 DCI subjects in Study 2 could have been so diagnosed (P < .0001) 
even if all such subjects actually had PFO' s. The conclusion is that either Assumption A is not true for 
TIE, or the sensitivity of TIE in Studies 1 and 2 was considerably higher than 0.29. A possible 
explanation for the latter scenario is that a sensitivity of 0.29 applies to standard clinical application, 
whereas experimenters in Studies I and 2 were especially meticulous about implementing TIE, perhaps 
with multiple trials if no PFO was detected. If this scenario is true, the effectiveness of TIE as a 
screening procedure against DCI may actually be higher than previously thought, provided the procedure 
is applied with the same care as in Studies 1 and 2. For example, a conservative estimate of the sensitivity 
ofTTE using data from Studies 1 and 2, would be to assume every DCI patient in these studies had a 
PFO. In this case 30 of 47 PFO' s would have been detected, (sensitivity = 30/47 = 0.64). Applying (5) 
yields 8, = 0.17. Using the separately obtained odds ratio of 8.6 for TTE (Table 7), with 8, = 0.17, yields 
a screening benefit ratio (4) of S, = 2.3, considerably higher than the value of l.24 obtained in Table 8, 
using the combined data with a sensitivity of 0.29. 
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Table I. Tabulated Results from Study 1. Method: TIE 
PFO Status DCI No Total 
DCI 
Yes (X= 1) 11 0 11 
No (X= 0) 7 12 19 
Total 18 12 30 
Table 2. Tabulated Results from Study 2. Method: TTE 
PFO Status DCI No Total 
DCI 
Yes (X= I) 19 15 34 
No (X= 0) 10 48 58 
Total 29 63 92 
Table 3. Tabulated Results from Study 3. Method: TCD 
PFO Status DCI No Total 
DCI 
Yes (X= 1) 27 13 40 
No (X= 0) 6 51 57 
Total 33 64 97 
Table 4. Tabulated Results from Study 4. Method: TEE 
PFO Status DCI No Total 
DCI 
Yes (X= 1) 16 5 21 
No (X= 0) 4 15 19 
Total 20 20 40 
Table 5. Tabulated Results from Study 5. Method: TEE 
PFO Status DCI No Total 
DCI 
Yes (X= 1) 4 9 13 
No (X= 0) 2 37 39 
Total 6 46 52 
Table 6. Characteristics of Diagnosis Methods (A. = overall incidence ofPFO = 0.270) 
k Method (Ie) Sensitivity Specificity ak 13k 8k 
I TIE 0.29 1.00 0.71 0.00 0.078 
2 TCD 0.91 0.93 0.01 0.07 0.297 
3 TEE 1.00 1.00 0.00 0.00 0.270 
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Table 7. Estimated DCI Odds Ratios (estimated separately) 
TIE TCD TEE 
Odds Ratio (ORJ 8.6 17.6 10.4 . 
95% Conf. Limits (3.5 , 21.0) (6.0, 51.7) (3.3,33.2) 
Table 8. Estimated DCI Risk and Screening Benefit Ratios (from combined data) 
TIE TCD TEE 
DCI Risk (pJ 4.1 10.3 20.6 
95% Conf. Limits (3.5, 4.7) (6.1 , 17.2) (8.3, 50.9) 
Screening Benefit (SJ 1.24 3.75 6.28 
95% Conf. Limits (1.20, 1.30) (2 .52, 5.79) (2.97, 14.47) 
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Venous bubbles from the limbs travel through the superior and inferior vena cava into the right atrium, 
then into the right ventricle. Then, those venous bubbles are normally filtered and eliminated in the lungs. 
If a patent foramen ovale is present, venous bubbles may crossover directly into the left atrium, left 
ventricle, aorta and finally into the arterial systemic circulation, shunting the lung filter. Bubbles into the 
carotids may embolize in the brain causing cerebral accidents. 
Three methods ofPFO detection. 
After the injection of an echo contrast agent, contrast-enhanced transthoracic echocardiography (c-TIE) 
is performed by placing a probe on the chest. However, there are failures to detect the PFO because 
remote views of the heart from the chest are not ideal. (specificity = 100%) 
After the injection of an echo contrast agent, contrast-enhanced transesophageal echocardiography (c-
TEE) is performed by placing an endoscopic probe into the oesophagus. This is the gold standard because 
the close location from the heart provides an excellent view of the heart. (sensitivity = 100%, specificity = 
100%) 
After the injection of an echo contrast agent, contrast-enhanced transcranial Doppler ultrasonography (c-
TeD) is performed by placing a probe on the temporal bone of the skull and detecting bubbles directly in 
the cerebral arteries. Standardized procedures allow a good sensitivity. (sensitivity> 90%, specificity ~ 
100%) 
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Figure 2. Point estimates and 95% confidence Limits for log risk ratios. Results calculated 
separately are shown as circles (point estimates) and dashed lines (confidence limits). Results 
calculated from combined data are shown as squares (point estimates) and solid lines (confidence 
limits). 
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